AutoSynVax vaccine (Agenus/PureMHC)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAutoSynVax vaccine (Agenus/PureMHC)
Drug Alias NameAutoSynVax
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgenus IncPure Mhc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgenus Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A